Targeted Treatment of Oral Cancer
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Dentistry, Oral Surgery and Oral Medicine".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 1017
Special Issue Editors
Interests: oral and maxillofacial surgery; facial aesthetic surgery; basic science; head and neck cancer
Special Issues, Collections and Topics in MDPI journals
Interests: genetics; molecular biology
Special Issue Information
Dear Colleagues,
Oral cancer is a significant global health concern, with increasing incidence rates and diverse treatment approaches. The Special Issue focuses on targeted treatment strategies that aim to improve therapeutic outcomes while minimizing adverse effects. By exploring personalized medicine approaches and innovative therapeutic modalities, this Special Issue aims to contribute to the advancement of clinical practice in oral cancer treatment.
The Special Issue invites original research articles and reviews that cover a wide range of topics related to the targeted treatment of oral cancer. We encourage submissions that address the following areas:
- Novel therapeutic agents and drug delivery systems;
- Immunotherapy and its role in oral cancer treatment;
- Combination therapies and their synergistic effects.
We hope that this collection of articles will facilitate the development of more effective and personalized treatment strategies, ultimately improving patient outcomes in the field of oral oncology.
Dr. Yasmine Ghantous
Dr. Claudia Malheiros Coutinho-Camillo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- precision medicine
- immunotherapy
- targeted drugs
- combination therapy
- tumor immune evasion
- clinical trials
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
